You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unresectable or metastatic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)

Recruiting
  • Unresectable/Metastatic Colorectal Cancer
  • Fruquintinib plus camrelizumab and capecitabine
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 19, 2023

Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

Not yet recruiting
  • Unresectable Metastatic Colorectal Cancer
  • (no location specified)
Oct 25, 2023

Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))

Not yet recruiting
  • Colorectal Neoplasms
  • Resin microspheres containing yttrium-90 (Y-90)
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023

Metastatic Colorectal Cancer Trial in Pisa (Bevacizumab, Irinotecan, Oxaliplatin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Pisa, Italia, Italy
    Francesca Vannini
Jan 4, 2023

Metastatic Carcinoma in the Adrenal Cortex, Stage III Adrenal Cortex Carcinoma AJCC v8, Stage IV Adrenal Cortex Carcinoma AJCC

Active, not recruiting
  • Metastatic Carcinoma in the Adrenal Cortex
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 28, 2023

Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

Not yet recruiting
  • Melanoma
  • +5 more
  • RC198 Injection
  • Auchenflower, Queensland, Australia
    Research Site
May 17, 2023

Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

Not yet recruiting
  • Recurrent Metastatic Melanoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jul 29, 2022

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI plus Bevacizumab, mFOLFOX6 Plus Bevacizumab)

Recruiting
  • Colorectal Cancer
  • mFOLFOXIRI plus Bevacizumab
  • mFOLFOX6 Plus Bevacizumab
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Jun 15, 2022

Breast Cancer, Breast Cancer Female Trial in China (surufatinib + fulvestrant + chidamide)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer Female
  • surufatinib + fulvestrant + chidamide
  • Anyang, China
  • +4 more
Jul 18, 2022

Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)

Recruiting
  • Unresectable or Metastatic Colorectal Cancer
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Mar 22, 2023

Unresectable Solid Tumor, Metastatic Solid Tumor, Locally Advanced Solid Tumor Trial in Australia (RC118 for injection)

Recruiting
  • Unresectable Solid Tumor
  • +2 more
  • RC118 for injection
  • Macquarie Park, New South Wales, Australia
  • +3 more
Feb 18, 2022

Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive

Not yet recruiting
  • Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
  • Non-investigational
  • (no location specified)
May 11, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX treatment
  • (no location specified)
Aug 9, 2023

Metastatic Breast Cancer, Unresectable Breast Cancer Trial in Saint Louis (DiviTum® TKa assay, CDK4/6 + Endocrine therapy)

Not yet recruiting
  • Metastatic Breast Cancer
  • Unresectable Breast Cancer
  • DiviTum® TKa assay
  • CDK4/6 + Endocrine therapy
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 27, 2023

Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Oct 5, 2023

Ampullary Carcinoma Trial (Surufatinib+Toripalimab+AG)

Not yet recruiting
  • Ampullary Carcinoma
  • (no location specified)
Sep 29, 2023

Solid Tumor, KRAS Mutation Trial (BI 3706674)

Not yet recruiting
  • Solid Tumor, KRAS Mutation
  • BI 3706674
  • (no location specified)
Sep 29, 2023

DESTINY Breast Respond HER2-low Europe

Not yet recruiting
  • Unresectable Breast Cancer
  • +2 more
  • Trastuzumab deruxtecan
  • (no location specified)
Jul 6, 2023

Bile Duct Adenocarcinoma Trial in Hangzhou (surufatinib plus cadonilimab)

Recruiting
  • Bile Duct Adenocarcinoma
  • surufatinib plus cadonilimab
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Oct 15, 2023

Solid Tumor Trial in Sydney (IBI129)

Not yet recruiting
  • Solid Tumor
  • Sydney, New South Wales, Austria
    St George private Hospital
Aug 6, 2023

Metastatic Breast Cancer Trial in Louisville (Palliative Radiation and Pembrolizumab)

Recruiting
  • Metastatic Breast Cancer
  • Palliative Radiation and Pembrolizumab
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Nov 5, 2021

Breast Cancer Trial (SHR-A1811 for injection ; capecitabine)

Not yet recruiting
  • Breast Cancer
  • SHR-A1811 for injection ; capecitabine
  • (no location specified)
May 4, 2023